T-RAOJO

Dosage form: liquid
Ingredients: TETRAHYDROZOLINE HYDROCHLORIDE 0.5mg in 1mL
Labeler: Promex, LLC
NDC code: 58988-0148

Medically reviewed by Drugs.com. Last updated on Jul 8, 2024.

Drug Facts

Active Ingredient

Tetrahydrozoline HCl 0.5%

Purpose

Redness reliever

Use

for the relief of redness of the eye due to minor eye irritations

Warnings

Ask a doctor before use if you have narrow angle glaucoma

When using this product

pupils may become enlarged temporarily
overuse may cause more eye redness
remove contact lenses before using
do not use if this solution changes color or become cloudy
do not touch tip of container to any surface to avoid contamination
replace cap after each use

Stop use and ask a doctor if

you feel eye pain
changes in vision occur
redness or irritation of the eye lasts
condition worsens or lasts more than 72 hours

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Put 1 to 2 drops in the affected eye(s) up to 4 times daily
children under 6 years of age: ask a doctor

Other information

store between 15° to 25°C (59°F to 77°F)

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, hydrochloric acid, purified water, sodium borate, sodium chloride

package label

Redness relief

T-RAOJO
tetrahydrozoline hydrochloride liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:58988-0148
Route of Administration	OPHTHALMIC	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TETRAHYDROZOLINE HYDROCHLORIDE (TETRAHYDROZOLINE)	TETRAHYDROZOLINE HYDROCHLORIDE	0.5 mg in 1 mL

Inactive Ingredients
Ingredient Name	Strength
BORIC ACID
SODIUM BORATE
EDETATE DISODIUM
BENZALKONIUM CHLORIDE
SODIUM CHLORIDE
WATER
HYDROCHLORIC ACID

Packaging
#	Item Code	Package Description
1	NDC:58988-0148-5	1 BOTTLE (BOTTLE) in 1 BOX
1		15 mL in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part349	07/17/2014

Labeler - Promex, LLC (789974388)

Revised: 07/2014

Document Id: b776833e-2216-4e51-aee0-e80aa0a44ae5

Set id: 779d736d-0d1a-47a1-b5b0-f7fc7d44d383

Version: 1

Effective Time: 20140717

Promex, LLC

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

T-RAOJO

Further information

See also:

Qulipta

Aimovig

Dupixent

Ubrelvy

Nurtec ODT

Xeomin

Dysport

Botox Cosmetic

Arazlo

Tazorac